Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Favrille completes $16.9mm private round

Executive Summary

Favrille (pharmacogenomics) raised $16.9mm through the private placement of Series B preferred shares. Sanderling Ventures led the financing, and was joined by new investors De Novo Ventures, Indofin, Lotus BioScience Investment Holdings. Other institutional and private investors, as well as existing investors Forward Ventures and Alloy Ventures also participated.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies